324 related articles for article (PubMed ID: 33516970)
1. Human coronaviruses in idiopathic Parkinson's disease: Implications of SARS-CoV-2's modulation of the host's transcriptome.
Vavougios GD
Infect Genet Evol; 2021 Apr; 89():104733. PubMed ID: 33516970
[TBL] [Abstract][Full Text] [Related]
2. Overlapping host pathways between SARS-CoV-2 and its potential copathogens: An in silico analysis.
Vavougios GD
Infect Genet Evol; 2020 Dec; 86():104602. PubMed ID: 33132111
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic profiles in Parkinson's disease.
Kurvits L; Lättekivi F; Reimann E; Kadastik-Eerme L; Kasterpalu KM; Kõks S; Taba P; Planken A
Exp Biol Med (Maywood); 2021 Mar; 246(5):584-595. PubMed ID: 33148011
[TBL] [Abstract][Full Text] [Related]
4. Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis.
Maleknia S; Tavassolifar MJ; Mottaghitalab F; Zali MR; Meyfour A
Mol Med; 2022 Aug; 28(1):86. PubMed ID: 35922752
[TBL] [Abstract][Full Text] [Related]
5. Outside-in induction of the IFITM3 trafficking system by infections, including SARS-CoV-2, in the pathobiology of Alzheimer's disease.
Vavougios GD; Nday C; Pelidou SH; Gourgoulianis KI; Stamoulis G; Doskas T; Zarogiannis SG
Brain Behav Immun Health; 2021 Jul; 14():100243. PubMed ID: 33817671
[TBL] [Abstract][Full Text] [Related]
6. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
Ruffini N; Klingenberg S; Schweiger S; Gerber S
Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
[TBL] [Abstract][Full Text] [Related]
7. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.
Conte C
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281186
[TBL] [Abstract][Full Text] [Related]
8. Genetic Exchange of Lung-Derived Exosome to Brain Causing Neuronal Changes on COVID-19 Infection.
Ahmed SSSJ; Paramasivam P; Kamath M; Sharma A; Rome S; Murugesan R
Mol Neurobiol; 2021 Oct; 58(10):5356-5368. PubMed ID: 34312772
[TBL] [Abstract][Full Text] [Related]
9. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
10. Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart.
Bräuninger H; Stoffers B; Fitzek ADE; Meißner K; Aleshcheva G; Schweizer M; Weimann J; Rotter B; Warnke S; Edler C; Braun F; Roedl K; Scherschel K; Escher F; Kluge S; Huber TB; Ondruschka B; Schultheiss HP; Kirchhof P; Blankenberg S; Püschel K; Westermann D; Lindner D
Cardiovasc Res; 2022 Jan; 118(2):542-555. PubMed ID: 34647998
[TBL] [Abstract][Full Text] [Related]
11. Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases.
Satu MS; Khan MI; Rahman MR; Howlader KC; Roy S; Roy SS; Quinn JMW; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1415-1429. PubMed ID: 33539530
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 dysregulation of PTBP1 and YWHAE/Z gene expression: A primer of neurodegeneration.
Vavougios GD
Med Hypotheses; 2020 Nov; 144():110212. PubMed ID: 33254518
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 with Alzheimer's/Parkinson's diseases.
Mahin A; Soman SP; Modi PK; Raju R; Keshava Prasad TS; Abhinand CS
J Neurovirol; 2024 Feb; 30(1):57-70. PubMed ID: 38167982
[TBL] [Abstract][Full Text] [Related]
14. Coordinated modification in expression levels of HSPA1A/B, DGKH, and NOTCH2 in Parkinson's patients' blood and substantia nigra as a diagnostic sign: the transcriptomes' relationship.
Asad Samani L; Ghaedi K; Majd A; Peymani M; Etemadifar M
Neurol Sci; 2023 Aug; 44(8):2753-2761. PubMed ID: 36973590
[TBL] [Abstract][Full Text] [Related]
15. The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1.
Alsamman AM; Zayed H
PLoS One; 2020; 15(12):e0243270. PubMed ID: 33301474
[TBL] [Abstract][Full Text] [Related]
16. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms highlighting the potential role of COVID-19 in the development of neurodegenerative diseases.
Rahmani B; Ghashghayi E; Zendehdel M; Baghbanzadeh A; Khodadadi M
Physiol Int; 2022 Jun; 109(2):135-162. PubMed ID: 35895572
[TBL] [Abstract][Full Text] [Related]
18. Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells.
Wang X; Zhao Y; Yan F; Wang T; Sun W; Feng N; Wang W; Wang H; He H; Yang S; Xia X; Gao Y
J Virol; 2021 Aug; 95(18):e0060021. PubMed ID: 34106002
[TBL] [Abstract][Full Text] [Related]
19. Favourable course in a cohort of Parkinson's disease patients infected by SARS-CoV-2: a single-centre experience.
Buccafusca M; Micali C; Autunno M; Versace AG; Nunnari G; Musumeci O
Neurol Sci; 2021 Mar; 42(3):811-816. PubMed ID: 33439387
[TBL] [Abstract][Full Text] [Related]
20. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.
Jaiswal V; Alquraish D; Sarfraz Z; Sarfraz A; Nagpal S; Singh Shrestha P; Mukherjee D; Guntipalli P; Sánchez Velazco DF; Bhatnagar A; Savani S; Halilaj E; Ruxmohan S; Cueva W
J Prim Care Community Health; 2021; 12():21501327211039709. PubMed ID: 34404266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
